Xenon Pharmaceuticals
XENE
#2963
Rank
S$6.69 B
Marketcap
S$70.20
Share price
-1.89%
Change (1 day)
52.09%
Change (1 year)

Xenon Pharmaceuticals (XENE) - Total debt

Total debt on the balance sheet as of December 2025 : S$10.23 Million

According to Xenon Pharmaceuticals's latest financial reports the company's total debt is S$10.23 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Xenon Pharmaceuticals - Total debt on balance sheet (from 2013 to 2025)

Total debt by year

Year Total debt Change
2025-12-31S$10.19 M-16.77%
2024-12-31S$12.25 M-14.9%
2023-12-31S$14.39 M2.93%
2022-12-31S$13.98 M25.32%
2021-12-31S$11.16 M154.53%
2020-12-31S$4.38 M-80.23%
2019-12-31S$22.17 M8.12%
2018-12-31S$20.51 M125.39%
2017-12-31S$9.1 M
2012-12-31S$2.03 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Coherus BioSciences
CHRS
S$52.43 M 412.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Atara Biotherapeutics
ATRA
S$21.85 M 113.47%๐Ÿ‡บ๐Ÿ‡ธ USA